Suppr超能文献

利用锝-99m-替曲膦显像对甲状旁腺进行定位

Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.

作者信息

Ishibashi M, Nishida H, Strauss H W, Kojima K, Fujito H, Watanabe J, Hiromatsu Y, Hayabuchi N

机构信息

Division of Nuclear Medicine, Kurume University School of Medicine, Japan.

出版信息

J Nucl Med. 1997 May;38(5):706-11.

PMID:9170432
Abstract

UNLABELLED

Preoperative localization of hyperactive parathyroid glands is useful to minimize operative time and reduce patient morbidity. This investigation compared the sensitivity of radionuclide imaging with 99mTc tetrofosmin with that of ultrasonography and magnetic resonance (MR) imaging in patients with hyperparathyroidism.

METHODS

Twenty-six patients with primary (n = 7) or secondary (n = 19) hyperparathyroidism were imaged with 99mTc tetrofosmin, ultrasound and MR imaging of the neck and thorax to localize the lesions. The presence of hyperparathyroidism was identified by an intact parathyroid hormone in vitro assay. The parathyroid/normal thyroid tissue activity ratio was calculated for all patients with evidence of an abnormality on tetrofosmin images. Pathological findings were compared with the results of imaging in 18 of the 26 patients who underwent parathyroidectomy.

RESULTS

Technetium-99m tetrofosmin scans demonstrated focal uptake in 46 glands of 26 patients. The uptake was categorized as slight in 78.3% (36/46) and intense (parathyroid/normal thyroid tissue activity ratio, > 1.4) in 21.7% (10/46). Ultrasonography and MR imaging identified 44 and 47 glands, respectively, in these patients. Eleven of the 18 patients who underwent parathyroidectomy within 1 mo after tetrofosmin imaging had hyperplastic glands, while 7 had parathyroid adenomas. Tetrofosmin imaging successfully localized 7 of 7 (100%) adenomas and 27 of 37 (73.0%) hyperplastic glands. The sensitivities of each technique for localizing abnormal parathyroid glands were 77.3% (34/44) for tetrofosmin imaging: 68.2% (20/44) for ultrasonography: and 68.2% (30/44) for MR imaging. Technetium-99m tetrofosmin uptake ratio in the 18 patients with surgical exploration was not proportional to several oxyphil cells.

CONCLUSION

Technetium-99m tetrofosmin parathyroid imaging may be useful for localizing abnormal glands in patients with primary and secondary hyperparathyroidism. The sensitivity of 99mTc tetrofosmin parathyroid imaging was high as compared to ultrasonography or MR imaging. The prolonged retention of tetrofosmin may not depend on the number of mitochondria-rich oxyphil cells.

摘要

未标记

术前定位功能亢进的甲状旁腺有助于缩短手术时间并降低患者发病率。本研究比较了99mTc替曲膦放射性核素显像与超声及磁共振(MR)成像在甲状旁腺功能亢进患者中的敏感性。

方法

26例原发性(n = 7)或继发性(n = 19)甲状旁腺功能亢进患者接受了99mTc替曲膦、颈部和胸部超声及MR成像检查以定位病变。通过体外完整甲状旁腺激素测定确定甲状旁腺功能亢进的存在。对所有在替曲膦图像上有异常证据的患者计算甲状旁腺/正常甲状腺组织活性比值。对26例接受甲状旁腺切除术的患者中的18例,将病理结果与影像学结果进行比较。

结果

99mTc替曲膦扫描显示26例患者的46个腺体有局灶性摄取。摄取被分类为轻度的占78.3%(36/46),强烈摄取(甲状旁腺/正常甲状腺组织活性比值>1.4)的占21.7%(10/46)。这些患者中超声和MR成像分别识别出44个和47个腺体。在替曲膦成像后1个月内接受甲状旁腺切除术的18例患者中,11例有增生性腺体,7例有甲状旁腺腺瘤。替曲膦成像成功定位了7例腺瘤中的7例(100%)和37例增生性腺体中的27例(73.0%)。每种技术定位异常甲状旁腺的敏感性分别为:替曲膦成像77.3%(34/44)、超声68.2%(20/44)、MR成像68.2%(30/44)。18例接受手术探查的患者中,99mTc替曲膦摄取率与嗜酸性细胞数量不成比例。

结论

99mTc替曲膦甲状旁腺显像可能有助于定位原发性和继发性甲状旁腺功能亢进患者的异常腺体。与超声或MR成像相比,99mTc替曲膦甲状旁腺显像的敏感性较高。替曲膦的长时间滞留可能不取决于富含线粒体的嗜酸性细胞数量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验